{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-02baf3-2021-06-11T11:40:07+01:00",
    "date": "2021-06-11T11:40:07+01:00",
    "ocid": "ocds-h6vhtk-02baf3",
    "initiationType": "tender",
    "tender": {
        "id": "CM/PHS/21/5642",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga)",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33651520",
            "description": "Immunoglobulins"
        },
        "mainProcurementCategory": "goods",
        "description": "NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga). The framework will commence on 1 June 2021 for a period of 7 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.",
        "lots": [
            {
                "id": "1",
                "description": "NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga). Period of framework agreement: 1 June 2021 to 31 December 2021 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "hasOptions": true,
                "options": {
                    "description": "Period of framework agreement: 1 June 2021 to 31 December 2021 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Total maximum framework agreement including extension options will be no more than 13 months."
                }
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33651520",
                        "description": "Immunoglobulins"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKC"
                    },
                    {
                        "region": "UKD"
                    },
                    {
                        "region": "UKE"
                    },
                    {
                        "region": "UKF"
                    },
                    {
                        "region": "UKG"
                    },
                    {
                        "region": "UKH"
                    },
                    {
                        "region": "UKI"
                    },
                    {
                        "region": "UKJ"
                    },
                    {
                        "region": "UKK"
                    },
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKN"
                    }
                ],
                "deliveryLocation": {
                    "description": "ITT lists Purchasing Points. Framework intended for use by the NHS in England, Scotland Northern Ireland, Dept of Health & Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
                },
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Negotiated without publication of a contract notice",
        "techniques": {
            "hasFrameworkAgreement": true
        },
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_EXTREME_URGENCY",
                "description": "Extreme urgency brought about by events unforeseeable for the contracting authority/entity and in accordance with the strict conditions stated in the directive"
            }
        ],
        "procurementMethodRationale": "An urgent need to secure additional supply of Human Normal Immunoglobulin as a result of the ongoing global supply shortages"
    },
    "awards": [
        {
            "id": "013184-2021-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-19257",
                    "name": "Octapharma Limited"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-2505",
            "name": "The NHS Commissioning Board (operating under the name of NHS England)",
            "identifier": {
                "legalName": "The NHS Commissioning Board (operating under the name of NHS England)"
            },
            "address": {
                "streetAddress": "2nd Floor, Rutland House",
                "locality": "Runcorn",
                "region": "UK",
                "postalCode": "WA7 2ES",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Philip Grieve",
                "email": "philip.grieve@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "http://www.england.nhs.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "MINISTRY",
                        "description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-19257",
            "name": "Octapharma Limited",
            "identifier": {
                "legalName": "Octapharma Limited"
            },
            "address": {
                "locality": "Manchester",
                "region": "UK",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-495",
            "name": "The High Court",
            "identifier": {
                "legalName": "The High Court"
            },
            "address": {
                "locality": "London",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-2505",
        "name": "The NHS Commissioning Board (operating under the name of NHS England)"
    },
    "contracts": [
        {
            "id": "013184-2021-1",
            "awardID": "013184-2021-1",
            "status": "active",
            "value": {
                "amount": 17595000,
                "currency": "GBP"
            },
            "dateSigned": "2021-06-10T00:00:00+01:00"
        }
    ],
    "language": "en"
}